Back

Clinical evidence from real-world studies on benefits of the early combination of metabolic and hemodynamic approaches.

27 August 2022 (10:30 - 10:40)
Organised by:
Congress Presentation Part of: Optimal medical treatment of chronic coronary syndromes CCS from the old model to a new combination approach Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS) Open Access ESC Congress 2022

About the speaker

Photo
Doctor Luis Henrique Gowdak

Sao Paulo (Brazil)

5 More presentations in this session

Presentation thumbnail
Introduction.
Professor G. Rosano (London, GB)
Slides Video
Presentation thumbnail
What constitutes optimal pharmacotherapy and when OMT should be considered failed?
Doctor R. Al-Lamee (London, GB)
Slides Video
Presentation thumbnail
Toward a combination approach in CCS: clinical rationale and patients' needs.
Professor F. Pinto (Lisbon, PT)
Slides Video
Presentation thumbnail
Q&A.
Slides Video
Presentation thumbnail
Conclusion.
Professor M. Marzilli (Pisa, IT)
Slides Video

Access the full session

Session thumbnail
Optimal medical treatment of chronic coronary syndromes CCS from the old model to a new combination approach
Video

The Event

Event poster

ESC Congress 2022

27 August 2022 10:30 CET
You may be interested in
thumbnail
Congress Session
Chronic ischaemic syndrome management in 2024: are we ready for the (r)evolution?
31 August 2024
thumbnail
Congress Session
Change of paradigm in dyslipidemia management
28 August 2022
thumbnail
Congress Presentation
When real-world data meet real patients' needs: how to optimally treat patients with chronic coronary syndromes in 2023?
26 August 2023
thumbnail
Congress Presentation
Addressing ischaemic disease with a metabolic agent
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources